Avalyn Pharma Inc. Common Stock reported earnings of -$ 0.67 per AVLN share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.67 |
| Earnings Per Share (Surprise) | -$ 0.67 (+$ 0.00333) |
Out of the last 4 earnings reporting periods, Avalyn Pharma Inc. Common Stock beat analysts’ expectations 2 times and fell short of expectations 2 time(s). Avalyn Pharma Inc. Common Stock reported earnings per share of -$ 0.67 in the last report surpassing an estimated EPS of -$ 0.67 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.67 | -$ 0.67 | - | - |
| Sep 2, 2026 | -$ 0.58 | - | - | |
| Aug 12, 2026 | -$ 0.78 | -$ 0.98 | - | - |
| Jun 3, 2026 | -$ 5.98 | -$ 21.83 | - | - |
Avalyn Pharma Inc. Common Stock’s stock was trading at $ 31.62 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, AVLN’s price decreased to $ 30.28 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.67 | $ 31.62 | $ 30.28 | |
| Sep 2, 2026 | | $ 35.28 | $ 35.44 | |
| Aug 12, 2026 | -$ 0.98 | $ 35.46 | $ 36.58 | |
| Jun 3, 2026 | -$ 21.83 | $ 25.72 | $ 26.99 |
Avalyn Pharma Inc. Common Stock released its most recent earnings reports in November 2026, September 2026, August 2026, June 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Avalyn Pharma Inc. Common Stock beat analysts’ expectations during the last earnings period by
